These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 34295947)

  • 21. Differential diagnosis of parkinsonism: a head-to-head comparison of FDG PET and MIBG scintigraphy.
    Brumberg J; Schröter N; Blazhenets G; Frings L; Volkmann J; Lapa C; Jost WH; Isaias IU; Meyer PT
    NPJ Parkinsons Dis; 2020 Dec; 6(1):39. PubMed ID: 33311476
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sensitivity and specificity of cardiac metaiodobenzylguanidine scintigraphy in the early diagnosis of Parkinson's disease.
    Brandl SJ; Braune S
    Clin Auton Res; 2019 Dec; 29(6):567-574. PubMed ID: 29869732
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MIBG scintigraphy in differential diagnosis of Parkinsonism: a meta-analysis.
    Treglia G; Cason E; Stefanelli A; Cocciolillo F; Di Giuda D; Fagioli G; Giordano A
    Clin Auton Res; 2012 Feb; 22(1):43-55. PubMed ID: 21792729
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of parameters of (123)I-metaiodobenzylguanidine scintigraphy for differential diagnosis in patients with parkinsonism: correlation with clinical features.
    Uchiyama Y; Momose M; Kondo C; Kusakabe K; Uchiyama S
    Ann Nucl Med; 2011 Aug; 25(7):478-85. PubMed ID: 21499991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Striatal dopamine activity and myocardial
    Oh YS; Kim JS; Yoo SW; Hwang EJ; Lyoo CH; Lee KS
    Parkinsonism Relat Disord; 2019 Jun; 63():156-161. PubMed ID: 30796009
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sequential imaging analysis using MIBG scintigraphy revealed progressive degeneration of cardiac sympathetic nerve in Parkinson's disease.
    Watanabe M; Takeda T; Nakamagoe K; Tamaoka A
    Eur J Neurol; 2011 Jul; 18(7):1010-3. PubMed ID: 21658161
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MIBG scintigraphy for differentiating Parkinson's disease with autonomic dysfunction from Parkinsonism-predominant multiple system atrophy.
    Chung EJ; Lee WY; Yoon WT; Kim BJ; Lee GH
    Mov Disord; 2009 Aug; 24(11):1650-5. PubMed ID: 19514077
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Validation of Iodine-131-meta-iodobenzylguanidine cardiac scintigraphy in Parkinsonism: A preliminary study.
    Xu D; Zhu W; Huo L; Zhu S; Li F; Wang H
    Parkinsonism Relat Disord; 2018 May; 50():69-73. PubMed ID: 29475590
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic performance of iodine-123-metaiodobenzylguanidine scintigraphy in differential diagnosis between Parkinson's disease and multiple-system atrophy: a systematic review and a meta-analysis.
    Treglia G; Stefanelli A; Cason E; Cocciolillo F; Di Giuda D; Giordano A
    Clin Neurol Neurosurg; 2011 Dec; 113(10):823-9. PubMed ID: 21962800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical Implications of Cardiac-MIBG SPECT in the Differentiation of Parkinsonian Syndromes.
    Shin DH; Lee PH; Bang OY; Joo IS; Huh K
    J Clin Neurol; 2006 Mar; 2(1):51-7. PubMed ID: 20396485
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prospective study of relevance of
    Alves Do Rego C; Namer IJ; Marcel C; Lefebvre F; Lagha-Boukbiza O; Renaud M; Tranchant C; Anheim M
    J Neurol; 2018 Sep; 265(9):2033-2039. PubMed ID: 29956027
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Usefulness of rCBF analysis in diagnosing Parkinson's disease: supplemental role with MIBG myocardial scintigraphy.
    Nagamachi S; Wakamatsu H; Kiyohara S; Fujita S; Futami S; Tamura S; Nakazato M; Yamashita S; Arita H; Nishii R; Kawai K
    Ann Nucl Med; 2008 Aug; 22(7):557-64. PubMed ID: 18756357
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is There Any Clinical Value of Adding 123I-Metaiodobenzylguanidine Myocardial Scintigraphy to 123I-Ioflupane (DaTscan) in the Differential Diagnosis of Parkinsonism?
    Stathaki M; Koukouraki S; Simos P; Boura I; Papadaki E; Bourogianni O; Tsaroucha A; Kapsoritakis N; Mitsias P; Spanaki C
    Clin Nucl Med; 2020 Aug; 45(8):588-593. PubMed ID: 32404715
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retrospective analysis of parkinsonian patients exhibiting normal (123)I-MIBG cardiac uptake.
    Mizutani Y; Ito S; Murate K; Hirota S; Fukui T; Hikichi C; Ishikawa T; Shima S; Ueda A; Kizawa M; Asakura K; Mutoh T
    J Neurol Sci; 2015 Dec; 359(1-2):236-40. PubMed ID: 26671120
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PSP as distinguished from CBD, MSA-P and PD by clinical and imaging differences at an early stage.
    Kurata T; Kametaka S; Ohta Y; Morimoto N; Deguchi S; Deguchi K; Ikeda Y; Takao Y; Ohta T; Manabe Y; Sato S; Abe K
    Intern Med; 2011; 50(22):2775-81. PubMed ID: 22082889
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical and pathological study on early diagnosis of Parkinson's disease and dementia with Lewy bodies].
    Orimo S
    Rinsho Shinkeigaku; 2008 Jan; 48(1):11-24. PubMed ID: 18386627
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiac 123I-MIBG scintigraphy can assess the disease severity and phenotype of PD.
    Saiki S; Hirose G; Sakai K; Kataoka S; Hori A; Saiki M; Kaito M; Higashi K; Taki S; Kakeshita K; Fujino S; Miaki M
    J Neurol Sci; 2004 May; 220(1-2):105-11. PubMed ID: 15140615
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is 123I-MIBG Scintigraphy Beneficial or Excessive for the Diagnosis of Parkinson's Disease in the Early Phase?
    Ikeda T; Ikenoshita S; Sakamoto F; Shiraishi S; Nakahara K; Masuda T; Yamashita S
    Neurodegener Dis; 2019; 19(2):88-95. PubMed ID: 31715596
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PR Prolongation and Cardiac 123I-MIBG Uptake Reduction in Parkinson's Disease.
    Mochizuki H; Ebihara Y; Ugawa Y; Ishii N; Taniguchi A; Nagamachi S; Shiomi K; Nakazato M
    Eur Neurol; 2015; 74(1-2):107-11. PubMed ID: 26303385
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Meta-analysis of 123I-MIBG cardiac scintigraphy for the diagnosis of Lewy body-related disorders.
    King AE; Mintz J; Royall DR
    Mov Disord; 2011 Jun; 26(7):1218-24. PubMed ID: 21480373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.